A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis

[1] Eichler AF(2007)Multidisciplinary management of brain metastases Oncologist 12 884-898

[2] Loeffler JS(2010)Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients Int J Radiat Oncol Biol Phys 77 655-661

[3] Sperduto PW(2006)Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2483-2491

[4] Chao ST(2011)Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 134-141

[5] Sneed PK(2012)Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): an American Society for Radiation Oncology evidence-based guideline Pract Radiat Oncol 2 210-225

[6] Aoyama H(2002)Stereotactic radiosurgery for patients with “radioresistant”brain metastases Neurosurgery 51 656-665

[7] Shirato H(2005)Outcome variation among so called “radioresistant” brain metastases treated with stereotactic radiosurgery Neurosurgery 56 936-945

[8] Tago M(2014)Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901):a multi institutional prospective observational study Lancet Oncol 15 387-395

[9] Kocher M(2011)A technique for stereotactic radiosurgery treatment planning with helical TomoTherapy Med Dosim 36 46-56

[10] Soffietti R(2006)A pathology-based substrate for target definition in radiosurgery of brain metastases Int J Radiat Oncol Biol Phys 66 187-194

[1] Eichler AF(2007)Multidisciplinary management of brain metastases Oncologist 12 884-898

[2] Loeffler JS(2010)Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients Int J Radiat Oncol Biol Phys 77 655-661

[3] Sperduto PW(2006)Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2483-2491

[4] Chao ST(2011)Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 134-141

[5] Sneed PK(2012)Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): an American Society for Radiation Oncology evidence-based guideline Pract Radiat Oncol 2 210-225

[6] Aoyama H(2002)Stereotactic radiosurgery for patients with “radioresistant”brain metastases Neurosurgery 51 656-665

[7] Shirato H(2005)Outcome variation among so called “radioresistant” brain metastases treated with stereotactic radiosurgery Neurosurgery 56 936-945

[8] Tago M(2014)Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901):a multi institutional prospective observational study Lancet Oncol 15 387-395

[9] Kocher M(2011)A technique for stereotactic radiosurgery treatment planning with helical TomoTherapy Med Dosim 36 46-56

[10] Soffietti R(2006)A pathology-based substrate for target definition in radiosurgery of brain metastases Int J Radiat Oncol Biol Phys 66 187-194